- Open Access
High-level intracellular expression of heterologous proteins in Brevibacillus choshinensis SP3 under the control of a xylose inducible promoter
© D'Urzo et al.; licensee BioMed Central Ltd. 2013
Received: 3 September 2012
Accepted: 29 January 2013
Published: 1 February 2013
In past years research has focused on the development of alternative Gram positive bacterial expression systems to produce industrially relevant proteins. Brevibacillus choshinensis is an easy to handle non-sporulating bacterium, lacking extracellular proteases, that has been already shown to provide a high level of recombinant protein expression. One major drawback, limiting the applicability of the Brevibacillus expression system, is the absence of expression vectors based on inducible promoters. Here we used the PxylA inducible promoter, commonly employed in other Bacillae expression systems, in Brevibacillus.
Using GFP, α-amylase and TcdA-GT as model proteins, high level of intracellular protein expression (up to 250 mg/L for the GFP) was achieved in Brevibacillus, using the pHis1522 vector carrying the B. megaterium xylose-inducible promoter (PxylA). The GFP expression yields were more than 25 fold higher than those reported for B. megaterium carrying the same vector. All the tested proteins show significant increment in their expression levels (2-10 folds) than those obtained using the available plasmids based on the P2 constitutive promoter.
Combining the components of two different commercially available Gram positive expression systems, such as Brevibacillus (from Takara Bio) and B. megaterium (from Mobitec), we demonstrate that vectors based on the B. megaterium PxylA xylose inducible promoter can be successfully used to induce high level of intracellular expression of heterologous proteins in Brevibacillus.
Bacterial expression systems for heterologous protein production are attractive because of the ability of the host cell to grow rapidly and at high density on inexpensive substrates. Escherichia coli is the most extensively used bacterial host for production of recombinant proteins. In spite of its large employment, E. coli h as several disadvantages that limit its applicability in the industrial production of proteins: 1) The expression of recombinant proteins often results in their accumulation as insoluble aggregates in inclusion bodies; 2) The separation of lipopolysaccharide (LPS), generally referred as pyrogenic endotoxins, requires the introduction of additional expensive purification steps . Therefore in past years, research has focused on the development of an alternative bacterial expression system. Gram positive bacteria do not produce LPS and are able to export proteins directly into the extracellular medium. Several expression systems for heterologous protein production in Gram positive bacteria, especially Bacilli, have already been successfully used to produce a number of industrial relevant proteins [2, 3]. Recently Takara Bio has released a Brevibacillus choshinensis (previously known as Bacillus brevis) expression system that is reported to guarantee high levels of extra cellular protein expression  although few data are available about the performance of the intracellular expression . Although less characterized than B. subtilis and B. megaterium, Brevibacillus choshinensis HPD31-SP3 (Brevibacillus) presents attributes that make it an advantageous host for heterologous protein production. A simple protocol to induce competence for DNA uptake up to 104cfu/μg without protoplast preparation is available from Takara Bio. Brevibacillus readily grows up to high cell density in shake flasks using either complex or chemically defined media suitable for uniform 15N isotopic protein labelling . Moreover, similarly to B. megaterium, the commercially available Brevibacillus strain does not form spores and presents limited intracellular and extracellular protease activities. All these aspects together make this bacterium attractive because it is more user-friendly compared to other Gram positive microorganisms. A clear disadvantage though is that all the commercially available expression vectors designed for Brevibacillus choshinensis SP3 rely on constitutive promoters and therefore do not allow a tightly controlled gene expression. This poses a limit to the expression of foreign proteins potentially toxic to the host cell and can impact on the final yield because of a sustained metabolic burden.
Efficient sugar-inducible promoters such as Plac, Pbad, and rhaPbad of E. coli[7–9] and Pxyl of Bacillus subtilis are widely used to optimize gene expression in the respective micro-organisms. For the Bacillae, one of the most commonly employed expression system is based on the PxylA inducible promoter of the xyl operon, which is usually localized on a freely replicating plasmid containing a copy of the xylR gene along with it . Repression of promoter activity in the absence of the inducer xylose is mediated by the repressor protein XylR. The selection of microbial hosts able to uptake xylose but deficient in its utilization is essential to maintain the concentration of the inducer constant during cultivation and achieve high expression yields . D-xylose metabolism in bacteria typically involves transport, isomerization to D-xylulose, and phosphorylation to D-xylulose-5-phosphate. The second and third steps of this pathway are catalyzed by D-xylose (D-glucose) isomerase (XylA) and xylulose kinase (XylB), respectively , while xylose uptake is mediated via at least two distinct transport systems: one involves a D-xylose–H+ or –Na+ symporter (XylE/XylT) [13, 14]. The second mechanism consists of genes for xylose ABC transport form a xylFGHR operon in which xylF, xylG, and xylH code for the periplasmic xylose-binding protein, ATPase, and permease, respectively .
No xylA homologues were found in the Brevibacillus brevis NBRC 100599 genome supporting that, as already reported, Brevibacillus species do not ferment D-xylose . However, the outcome of a xylose induction system in Brevibacillus is not obvious because no homologues of the XylE/XylT and XylFGH systems, involved in D-xylose uptake in other organisms , are present in the Brevibacillus genome.
To confirm the suitability of a PxylA promoter in Brevibacillus, we compared the intra/extra-cellular expression level of the green fluorescent protein (GFP) , α-amylase from B. licheniformis and the Y283A-D285A-D287A mutant of TcdA catalytic domain from Clostridium difficile (TcdA-GT) , using the xylose-inducible promoter PxylA and the strong constitutive promoter P2. Here we show that the PxylA xylose inducible promoter is able to induce high levels of intracellular expression of heterologous protein in Brevibacillus.
The Brevibacillus genome was analyzed to find homologues of the proteins known to be involved in xylose uptake and metabolism in other organisms and therefore to evaluate its suitability as a host for protein expression using the xylose induction. A PSI-BLAST search (E <0,1) was performed to detect putative xylose import systems in the Brevibacillus brevis NBRC 100599 genome. No homologues with high a degree of identity to the XylA, XylE and XylF genes were found. When using the E. coli XylA (GenBank: NP_418022) as input, no putative homologues were found in the Brevibacillus brevis NBRC 100599 genome. The BLAST search using the E. coli XylE (GenBank: NP_418455) as input could only identify an alpha-ketoglutarate permease (YP_002770906) with low sequence identity with E. coli XylE (20% identity) and B. megaterium XylT (18,5% identity). The BLAST search using E. coli XylF (GenBank: AAB18543) as input revealed two putative ABC transporter substrate binding proteins (mglb and BBR47_06790). The mglb protein showed 23,8% identity with XylF and the absence of 3 of the 5 xylose binding residues , (D135, N137, K242). The BBR47_06790 showed 17,8% identity when compared to XylF and once again the absence of 3 of the 5 xylose binding residue D135, N196, K242.
Brevibacillus growth profile in complex and minimal media
First, we determined the rate of growth of Brevibacillus in shaking flask containing TM medium and incubated at different temperatures (Additional file 1: Figure S1). A final OD600 of about 5 was obtained growing Brevibacillus in a temperature range between 25°C and 37°C, while no significant growth was observed at 20°C after 120 h. To confirm the inability to metabolize xylose, Brevibacillus was cultured in minimal medium with either glucose or xylose as unique carbon source. After 24 h of culture at 37°C, 150 rpm in shaking flask, no growth (OD600 <0,1) was observed for Brevibacillus using chemically defined medium containing xylose while an OD600 of about 1 was detected for Brevibacillus grown in the same media containing glucose.
Intracellular GFP expression in Brevibacillus
Intracellular α-amylase expression in Brevibacillus
Intracellular TcdA-GT expression in Brevibacillus
TcdA-GT production by Brevibacillus carrying the TcdA-GT-pHis1522 induced with 0,5% of xylose was compared to those obtained with the α-amylase-pNI vector. The influence of temperature on protein yield was assessed for all clones by performing SDS-PAGE analysis and BCA quantification of the IMAC purified samples (Figure 2C). In both TcdA-GT-pNI and TcdA-GT-pHis1522 Brevibacillus clones, the best results in terms of protein expression and stability were observed at 25°C, while lower expression levels were detected using both vectors at 37°C and 30°C as already observed for α-amylase (data not shown).
Extracellular GFP expression in Brevibacillus
Extracellular α-amylase expression in Brevibacillus
Purification of the recombinant GFP and TcdA-GT
To quantify the amount of recombinant GFP and TcdA-GT produced by different expression vectors, 50 mL of each culture was collected at the peak of fluorescence, purified by IMAC chromatography and the amount of purified protein was estimated by BCA assay. The result confirms that pHis1522 induces higher level of GFP and TcdA-GT intracellular protein expression compared to the pNI-His vector. However, no improvement of extracellular protein production was observed using pHis1522 in comparison to pNC-His vector, using the same secretion signal peptide. In fact, the GFP-pHis1522 clone produced the highest protein yield (250 mg/L) (Figure 5) with roughly a 10 fold higher yield compared to all the other tested clones and TcdA-GT-pHis1522 clone produced about 3 fold higher yield than TcdA-GT-pNI clone (15 mg/L vs 6 mg/L) (Figure 5). In contrast, the yield achieved using the SEC-GFP-pHis1522 (20 mg/L) was slightly lower than that obtained when using the GFP-pNC vector (30 mg/L). These values are in agreement with the relative amount of GFP predicted using the fluorescence assay.
In recent years, various studies have revealed that non-pathogenic Gram positive Bacillae are attractive hosts for the expression of heterologous proteins. They show in fact several favourable features, such as the natural capacity to secrete which allows the exporting of proteins directly into the extracellular medium, and the absence of endotoxins which make it highly attractive for the industrial production of pharmaceutical proteins. Several factors including (1) lack of suitable expression vectors, (2) plasmid instability, (3) presence of proteases, (4) lack of spore deficient strains, and (5) low transformation efficiency, limit the choice of expression systems based on Bacillae with respect to E. coli. Recently, Takara Bio has released a Brevibacillus Expression System that overcomes the majority of these limitations by combining an easy to handle expression host with the most favorable features typical of Gram positive bacteria. A number of different proteins such as bacterial α-amylase , cholera toxin B subunit B , human epidermal growth factor  and human interleukin-2  have already been successfully secreted in high amounts by using this system. Moreover, the intracellular expression, though less explored, has recently permitted the production of GT-domain of clostridial TcdA . In this work for the first time, we successfully employ the PxylA inducible promoter of B. megaterium to produce heterologous proteins in Brevibacillus. The selection of an expression host able to import the xylose into the cells but deficient in its utilization is essential to maintain a constant level of inducer during the culture and to achieve a high efficiency of target gene induction. A BLAST search across the Brevibacillus brevis NBRC 100599 genome did not reveal any XylA and XylB homologues. These findings, coupled with the inability of Brevibacillus to grow in minimal medium with xylose as the sole carbon source, confirm that, differently from B. megaterium, the Brevibacillus strain used in this work is naturally deficient in xylose utilization. In agreement with this, the use of pHis1522 vector, carrying the xylose inducible promoter in Brevibacillus, allow a high level of intracellular protein expression. The yield obtained for GFP (250 mg/L) is more than 25 fold higher than that reported for B. megaterium carrying the same expression vector , more than 10-fold higher compared to that obtained with Brevibacillus carrying the GFP-pNI vector (Figure 5) based on the P2 constitutive promoter and, finally, comparable with E. coli in a fed-batch cultivation . The yields obtained for both α-amylase and TcdA-GT using the pHis1522 vector were about 2-3 fold higher compared to those obtained using the pNI-His vector. In addition "non-induced cultures" (Figures 1, 2, 3 and 4) confirmed that protein expression is well repressed in absence of xylose. The protein induction was maintained for long term after the addiction of xylose (up to 60-120 h) and the expression level was not affected by the xylose concentration. Consequently Brevibacillus is deficient in the xylose utilization but is also able to uptake the sugar into the cells even in absence of the representative genes required for xylose transport. Further investigations will be necessary to understand if an alternative uncharacterized xylose import system is present in Brevibacillus or whether the uptake of xylose could occur via a transporter with broad substrate specificity, as already observed with B. subtilis. On the other hand, the levels of secreted proteins obtained using both the pNC-His and pHis1522 vectors were lower than expected and comparable to those obtained with pNI-His. While no published data are available regarding the GFP production using Brevibacillus, a high level of α-amylase production was already reported using the same expression vector . The low yields obtained using the SEC-GFP-pHis1522 may not be due to the low efficiency of the xylose induction system that performs robustly in terms of intracellular protein expression, but rather to the saturation of the protein secretion system. Further investigation will be necessary to understand if the replacement of the Brevibacillus R6L2 signal peptide with others derived from Brevibacillus or B. megaterium could properly enhance the secretion ability of Brevibacillus in pHis1522, carrying the PxylA B. megaterium promoter. However, the good performance that the xylose inducible promoter showed in terms of intracellular protein expression, the absence of LPS and the simple lysis method make Brevibacillus attractive, in particular for all those proteins that, similarly to TcdA-GT, are poorly expressed, toxic or degraded in E. coli
Here we demonstrated, for the first time, that the PxylA inducible promoter of B. megaterium can efficiently induce long term expression of heterologous proteins in Brevibacillus. Xylose induction in Brevibacillus produces up to 250 mg/L of intracellular GFP in shake flask cultures. The availability of controllable vectors, carrying a well repressed and regulated promoter, could largely extend the application of Brevibacillus in protein production. In conclusion, by shuffling the components of two different commercially available Gram positive expression systems, such as Brevibacillus (from Takara Bio) and B. megaterium (from Mobitec), we created a new original blend of potential advantage for proteins that in E. coli are either degraded or poorly expressed.
Chemicals and enzymes
α-amylase from Bacillus licheniformis (catalog number A-4551), anti-α-amylase antibody produced in rabbit (catalog number A8273-1VL), D-(+)-xylose (catalog number W360600), and antibiotics were purchased from Sigma Chemical Co. (St. Louis, MO, USA). The EnzChek_Ultra amylase assay kit (catalog number E33651) and the polyclonal anti-GFP Rabbit Serum (catalog number A6455) were purchased from Life Technologies Corp. (Carlsbad, CA, USA). ECL Western Blotting Detection Reagents (catalog number RPN2106), Amersham Hyperfilm ECL (catalog number 28-90-68-37) were purchased from GE Healthcare (Chalfont St. Giles, United Kingdom).
A protein BLAST search (E <0,1)  was performed in order to detect putative E. coli XylA, XylE, XylT and XylF homologues in the Brevibacillus brevis NBRC 100599 genome. A further BLAST search was performed to detect the genes codifying for putative XylG, XylH and XylR homologues and verify their respective genomic localization in Brevibacillus.
A new version of pNI-His, pNC-His (Takara Bio) and pHis1522 (Mobitec) vectors (respectively pNI/ccdB, pNC/ccdB and pHis1522/ccdB) were constructed to express N-term His tagged proteins and to limit the background of transformants coming from the empty vectors in the PIPE cloning. The His-TEV-CcdB-Chloramphenicol cassette was amplified from the SpeedET vector  using the ccdB_F and ccdB_R primers (Additional file 3: Table S1) and cloned into the multicloning sites (MCS). The pNI-His, pNC-His and pHis1522 vectors were amplified using the VpNI_F/VpNI_R primers, VpNC_F/ VpNC_R primers and VpHis1522_F/VpHis1522_R primers respectively (Additional file 3: Table S1). The unpurified insert-PCR (I-PCR) and vector-PCR (V-PCR) were mixed 1:1 (v/v) and transformed in 25 μL of E. coli DB3.1 competent cells (Additional file 4: Table S2).
Plasmids used in this study
In this study a GFP variant, called GFPmut1 or enhanced green fluorescent protein (EGFP) with amino acid exchanges in the chromophore (F64L, S65T) was used (here referred to as GFP). This double amino acid exchange results in a shift of about 100 nm in the excitation maximum to 490 nm compared to the wild-type GFP and also in a 30-fold increase of fluorescence intensity.
Moreover, to compare the intracellular expression using P2 and PxylA promoters, the Y283A-D285A-D287A mutant of TcdA catalytic domain from Clostridium difficile was amplified from TcdA-GT-pNI  and introduced into pHis1522 (Mobitec) (Table 1). To construct the GFP-pNI and GFP-pNC expression vectors (Table 1), the GFP  gene was amplified by PCR using the GFP_BamHI_F and GFP_XhoI_R primers (Additional file 3: Table S1). The PCR products were digested with BamHI/XhoI and then ligated respectively into the pNI-His and pNC-His vectors using E. coli TOP10 (Additional file 4: Table S2). The recombinant GFP-pHis1522, α-amylase-pNI, α-amylase-pNC, α-amylase-pHis1522 and TcdA-GT-pHis1522 expression vectors were generated by the polymerase incomplete primer extension (PIPE) method . The selected genes were amplified by PCR using the F-GFP/R-GFP primers, F-amy/R-amy primers and F-tcdA/R-tcdA primers respectively, which included extensions complementary to the desired vector cloning site. The pNI/ccdB, pNC/ccdB and pHis1522/ccdB vectors were then amplified by PCR using the Vp_F/Vp_R primers (pNI-His and pNC-His vectors) and the ForpHis1522/RevpHis1522 primers (pHis1522 vector) (Additional file 3: Table S1). The unpurified I-PCR and V-PCR were mixed 1:1 (v/v) and the mixture was transformed in 25 μL of E. coli HK100 competent cells (Additional file 4: Table S2). The R2L6 signal-peptide , a modified version of the signal peptide (SP) coding region of the Brevibacillus cell wall protein (CWP) gene was added at the N-term of GFP- α-amylase- sequences in the pHis1522 clone to generate the SEC-GFP-pHis1522 and SEC-α-amylase-pHis1522 expression vectors . The GFP-pHis1522 and α-amylase-pHis1522 vectors were amplified by PCR using the SecGFP_F/SecGFP_R and SecAmylase_F/SecAmylase_R primers, which included 19bp complementary extensions coding for the R2L6 signal peptide. A 2 μL aliquot of unpurified vector-PCR product was transformed in 25 μL of E. coli HK100 competent cells. The vectors were amplified in E. coli, extracted with a The E.Z.N.A.® Plasmid Mini Kit II (Omega Biotek, GA, USA) and their DNA sequences were confirmed by DNA sequencing.
Growth medium composition
TM medium (1% glucose, 1% polypeptone, 0,5% meat extract, 0,2% yeast extract, 0,001% FeSO4 ×7H2O, 0,001% MnSO4 ×4H2O, and 0,0001% ZnSO4 ×7H2O) and minimal medium (0,85% Na2HPO4 ×2H2O, 0,3% KH2PO4, 0,3% glucose or xylose, 0,1% (NH4)2SO4, 0,05% NaCl; 0,01% MgSO4, 0,0001% Biotin, 0,0001% trace element solution) were used to grow Brevibacillus choshinensis SP3 (Additional file 4: Table S2).
Brevibacillus growth in chemically defined medium
An pre-culture of Brevibacillus grown in TM medium at 30°C, 150 rpm for 16 h and then diluted 100 times in 50 mL of minimal medium containing alternatively 1,5% glucose or 1,5% xylose as unique carbon source. The bacterial cells were grown in a 250 mL shaking flask at 37°C, 150 rpm 24 h.
Brevibacillus competent cells were prepared according to the manufacturer’s instructions (Takara Bio Inc., Shiga, Japan). All the expression vectors were transformed into Brevibacillus choshinensis SP3 using the tris-polyethylene glycol method  as described by Takara Bio manual using 0,5-2 μg of total DNA. 10 μg/mL of neomycin and 20 μg/mL of tetracycline were respectively used to transform the plasmid constricts.
Shaking-flask production of recombinant GFP, α-amylase and TcdA-GT using Brevibacillus
To screen for protein production freshly transformed cells were grown overnight in 10 mL of TM medium containing 10 μg/mL of neomycin (pNI-His and pNC-His vectors) or 20 μg/mL of tetracycline (pHis1522 and SEC-pHis1522 vectors) at 30°C, 150 rpm. Pre-inoculums were inoculated 1:100 in 50 mL of the same media and grown at 150 rpm at 25°C, 30°C and 37°C. Recombinant expression of the selected proteins under transcriptional control of the xylose-inducible promoter, were induced by the addition of xylose at different concentrations (0,5-1-2%) at OD600 about 1,5. Intracellular GFP, α-amylase and TcdA-GT samples were withdrawn at different growth phases, and subjected to Western blotting analysis, GFP fluorescence determination and α-amylase activity assay as described below.
GFP fluorescence assay
Recombinant GFP production was monitored via fluorescence spectroscopy on a black flat bottom 96 well using a Tecan Infinite M200 reader (Tecan, Mannedorf, Switzerland). The excitation wavelength was 395 nm (bandwidth 10 nm) and the emission spectrum was recorder with gain 80 in the 420-600 nm range (bandwidth 10 nm). To eliminate background fluorescence, the intensity recorded at 480 nm was subtracted from that recorded at 510 nm.
1 OD600 of each bacterial culture was collected and centrifuged. To monitor the intracellular expression of GFP (for GFP-pNI and GFP-pHis1522 clones), the cell pellet was washed with 1 mL of PBS and finally resuspended in 100 μL of PBS. To reduce the fluorescence background due to the media, and reveal the secreted GFP (GFP-pNC and SEC-GFP-pHis1522 clones), the supernatant was diluted up to 2 mL with PBS buffer and subsequently concentrated (from 2 mL to 200 μL), using Amicon Ultra-0.5 10 KDa (Millipore, Billerica, USA) for 2 times. A final volume of 100 μL was finally transferred into the 96-black flat bottom well plate (Greiner Bio-One, Frickenhausen, Germany) and the fluorescence emission spectra were recorded. The GFP fluorescence (expressed as fluorescence unit = F.U.) was monitored to evaluate the relative amount of protein expressed under the different conditions tested.
α- amylase quantification
To qualitatively and quantitatively asses the ability of the different expression vector to produce α-amylase in Brevibacillus, the α-amylase activity was measured by EnzChek amylase Assay Kit (Life Technologies Corp., Carlsbad, CA, USA). Briefly, the culture supernatant (SEC-α-amylase-pHis1522) or the Brevibacillus lysate (α-amylase-pHis1522) was mixed with 200 μg/mL of substrate solution (starch-BODIPY FL conjugate) and incubated for 30 minutes at 25°C. Fluorescence intensity was measured at excitation and emission wavelengths of 470 and 530 nm in an Infinite M200 spectrophotometer microplate reader (Tecan, Mannedorf, Switzerland). Analysis of culture supernatant and Brevibacillus lysate from the GFP-pHis1522 and SEC-GFP-pHis1522 clones were also performed as negative control.
Western Blot analysis
To analyze the intracellular expression, the bacterial cells were suspended in CelLytic Express (Sigma-Aldrich, St. Louis, MO, USA) incubated at 25°C for 30 minutes and the cellular debris was removed by centrifugation. Soluble fractions, derived from 0,08 OD600 of lysed bacteria, were loaded and resolved on 4-12% NuPAGE precast gels (Life Technologies Corp. Carlsbad, CA, USA) and transferred to nitrocellulose. To analyze the extracellular expression, the bacterial cells were centrifuged and 20 μL of culture supernatant were loaded and resolved on 4-12% NuPAGE precast gels (Life Technologies Corp., Carlsbad, CA, USA) and transferred to nitrocellulose. In both cases, the membranes were probed with rabbit antibodies directed against GFP (1:100 dilution) or against α-amylase (1:1000 dilution), followed by a rabbit anti-rabbit horseradish peroxidase-conjugated secondary antibody (Dako, Glostrup, Denmark). Bands were then visualized using an Opti-4CN substrate kit (Bio-Rad Laboratories, Hercules, CA) or SuperSignal West Pico chemiluminescent substrate (Pierce, IL, USA).
Western Blot analysis were performed for all the conditions (37, 30 and 25°C) but we reported in Figures 1, 2, 3, 4 only that one providing the highest levels of protein expression, as estimated by GFP fluorescence assay or amylase activity assay Kit.
GFP and TcdA-GT purification
GFP and TcdA-GT purification by IMAC chromatography was performed to better estimate the protein yields achievable for each strain/vector combination. For purification of intracellular GFP and TcdA-GT, cells were harvested by centrifugation, re-suspended in 10 mL of binding buffer (Tris 20 mM, NaCl 300 mM, Imidazole 10 mM, pH=8,0) and finally disrupted by sonication. Cellular debris were removed by centrifugation (8000 rpm, 4°C, 30 min). The supernatant was loaded onto a PD-10 gravity flow column (GE Healthcare, Chalfont St. Giles, United Kingdom), packed with 2 mL of Ni-NTA FF resin (Qiagen, Hilden, Germany). For purification of extracellular GFP, cells were harvested by centrifugation, culture supernatant was filtered through a 0,22 μm filter (Millipore, Billerica, USA) and loaded onto a column prepared as indicated above. 2 washing step were perfomed using 40 mL of binding buffer and 40 mL of washing buffer (Tris 20 mM, NaCl 300 mM, Imidazole 20 mM pH=8,0) and the bound protein was then eluted with the elution buffer (Tris 20 mM, NaCl 300 mM, Imidazole 300 mM pH=8,0). SDS-PAGE and BCA assay (Pierce, IL, USA) were used to check protein purity and concentration, respectively.
We wish to thank S. Buccato for helpful discussions about Gram-positive expression systems, S. Pasquini for technical support in preparing the culture media and M. Bottomley for valuable discussion and critical review of the manuscript.
ND is the recipient of a Novartis fellowship from the Ph.D. program in Functional Biology of Molecular and Cellular Systems of the University of Bologna.
- Petsch D, Anspach FB: Endotoxin removal from protein solutions. J Biotechnol. 2000, 76: 97-119. 10.1016/S0168-1656(99)00185-6.View ArticleGoogle Scholar
- Terpe K: Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol. 2006, 72: 211-222. 10.1007/s00253-006-0465-8.View ArticleGoogle Scholar
- Yang Y, Biedendieck R, Wang W, Gamer M, Malten M, Jahn D, et al: High yield recombinant penicillin G amidase production and export into the growth medium using Bacillus megaterium. Microb Cell Fact. 2006, 5: 36- 10.1186/1475-2859-5-36.View ArticleGoogle Scholar
- Udaka S, Yamagata H: High-level secretion of heterologous proteins by Bacillus brevis. Methods Enzymol. 1993, 217: 23-33.View ArticleGoogle Scholar
- D'Urzo N, Malito E, Biancucci M, Bottomley MJ, Maione D, Scarselli M, et al: The structure of Clostridium difficile toxin A glucosyltransferase domain bound to Mn2+ and UDP provides insights into glucosyltransferase activity and product release. FEBS J. 2012, 279: 3085-3097. 10.1111/j.1742-4658.2012.08688.x.View ArticleGoogle Scholar
- Tanio M, Tanaka T, Kohno T: 15N isotope labeling of a protein secreted by Brevibacillus choshinensis for NMR study. Anal Biochem. 2008, 373: 164-166. 10.1016/j.ab.2007.10.011.View ArticleGoogle Scholar
- Guzman LM, Belin D, Carson MJ, Beckwith J: Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol. 1995, 177: 4121-4130.Google Scholar
- Newman JR, Fuqua C: Broad-host-range expression vectors that carry the L-arabinose-inducible Escherichia coli araBAD promoter and the araC regulator. Gene. 1999, 227: 197-203. 10.1016/S0378-1119(98)00601-5.View ArticleGoogle Scholar
- Wegerer A, Sun T, Altenbuchner J: Optimization of an E. coli L-rhamnose-inducible expression vector: test of various genetic module combinations. BMC Biotechnol. 2008, 8: 2- 10.1186/1472-6750-8-2.View ArticleGoogle Scholar
- Kim L, Mogk A, Schumann W: A xylose-inducible Bacillus subtilis integration vector and its application. Gene. 1996, 181: 71-76. 10.1016/S0378-1119(96)00466-0.View ArticleGoogle Scholar
- Rygus T, Hillen W: Catabolite repression of the xyl operon in Bacillus megaterium. J Bacteriol. 1992, 174: 3049-3055.Google Scholar
- Bhosale SH, Rao MB, Deshpande VV: Molecular and industrial aspects of glucose isomerase. Microbiol Rev. 1996, 60: 280-300.Google Scholar
- Lam VM, Daruwalla KR, Henderson PJ, Jones-Mortimer MC: Proton-linked D-xylose transport in Escherichia coli. J Bacteriol. 1980, 143: 396-402.Google Scholar
- Davis EO, Henderson PJ: The cloning and DNA sequence of the gene xylE for xylose-proton symport in Escherichia coli K12. J Biol Chem. 1987, 262: 13928-13932.Google Scholar
- Erbeznik M, Strobel HJ, Dawson KA, Jones CR: The D-xylose-binding protein, XylF, from Thermoanaerobacter ethanolicus 39E: cloning, molecular analysis, and expression of the structural gene. J Bacteriol. 1998, 180: 3570-3577.Google Scholar
- Nakamura LK: Bacillus brevis Migula 1900 taxonomy: reassociation and base composition of DNA. Int J Syst Bacteriol. 1991, 41: 510-515. 10.1099/00207713-41-4-510.View ArticleGoogle Scholar
- Sumiya M, Davis EO, Packman LC, McDonald TP, Henderson PJ: Molecular genetics of a receptor protein for D-xylose, encoded by the gene xylF, in Escherichia coli. Receptors Channels. 1995, 3: 117-128.Google Scholar
- Shimomura O, Johnson FH, SAIGA Y: Extraction, purification and properties of aequorin, a bioluminescent protein from the luminous hydromedusan, Aequorea. J Cell Comp Physiol. 1962, 59: 223-239. 10.1002/jcp.1030590302.View ArticleGoogle Scholar
- Yuuki T, Nomura T, Tezuka H, Tsuboi A, Yamagata H, Tsukagoshi N, et al: Complete nucleotide sequence of a gene coding for heat- and pH-stable alpha-amylase of Bacillus licheniformis: comparison of the amino acid sequences of three bacterial liquefying alpha-amylases deduced from the DNA sequences. J Biochem. 1985, 98: 1147-1156.Google Scholar
- Sooriyaarachchi S, Ubhayasekera W, Park C, Mowbray SL: Conformational changes and ligand recognition of Escherichia coli D-xylose binding protein revealed. J Mol Biol. 2010, 402: 657-668. 10.1016/j.jmb.2010.07.038.View ArticleGoogle Scholar
- Tsukagoshi N, Iritani S, Sasaki T, Takemura T, Ihara H, Idota Y, et al: Efficient synthesis and secretion of a thermophilic alpha-amylase by protein-producing Bacillus brevis 47 carrying the Bacillus stearothermophilus amylase gene. J Bacteriol. 1985, 164: 1182-1187.Google Scholar
- Ichikawa Y, Yamagata H, Tochikubo K, Udaka S: Very efficient extracellular production of cholera toxin B subunit using Bacillus brevis. FEMS Microbiol Lett. 1993, 111: 219-224. 10.1111/j.1574-6968.1993.tb06389.x.View ArticleGoogle Scholar
- Ebisu S, Takagi H, Kadowaki K, Yamagata H, Udaka S: The efficient production of human epidermal growth factor by Bacillus brevis. Ann N Y Acad Sci. 1996, 782: 115-122. 10.1111/j.1749-6632.1996.tb40553.x.View ArticleGoogle Scholar
- Takimura Y, Kato M, Ohta T, Yamagata H, Udaka S: Secretion of human interleukin-2 in biologically active form by Bacillus brevis directly into culture medium. Biosci Biotechnol Biochem. 1997, 61: 1858-1861. 10.1271/bbb.61.1858.View ArticleGoogle Scholar
- Rygus T, Scheler A, Allmansberger R, Hillen W: Molecular cloning, structure, promoters and regulatory elements for transcription of the Bacillus megaterium encoded regulon for xylose utilization. Arch Microbiol. 1991, 155: 535-542. 10.1007/BF00245346.View ArticleGoogle Scholar
- Biedendieck R, Yang Y, Deckwer WD, Malten M, Jahn D: Plasmid system for the intracellular production and purification of affinity-tagged proteins in Bacillus megaterium. Biotechnol Bioeng. 2007, 96: 525-537. 10.1002/bit.21145.View ArticleGoogle Scholar
- Aucoin MG, McMurray-Beaulieu V, Poulin F, Boivin EB, Chen J, Ardelean FM, et al: Identifying conditions for inducible protein production in E. coli: combining a fed-batch and multiple induction approach. Microb Cell Fact. 2006, 5: 27- 10.1186/1475-2859-5-27.View ArticleGoogle Scholar
- Krispin O, Allmansberger R: The Bacillus subtilis AraE protein displays a broad substrate specificity for several different sugars. J Bacteriol. 1998, 180: 3250-3252.Google Scholar
- Yamagata H, Adachi T, Tsuboi A, Takao M, Sasaki T, Tsukagoshi N, et al: Cloning and characterization of the 5' region of the cell wall protein gene operon in Bacillus brevis 47. J Bacteriol. 1987, 169: 1239-1245.Google Scholar
- Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, et al: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25: 3389-3402. 10.1093/nar/25.17.3389.View ArticleGoogle Scholar
- Sagiya Y, Yamagata H, Udaka S: Direct high-level secretion into the culture medium of tuna growth hormone in biologically active form by Bacillus brevis. Appl Microbiol Biotechnol. 1994, 42: 358-363.Google Scholar
- Cormack BP, Valdivia RH, Falkow S: FACS-optimized mutants of the green fluorescent protein (GFP). Gene. 1996, 173: 33-38. 10.1016/0378-1119(95)00685-0.View ArticleGoogle Scholar
- Klock HE, Koesema EJ, Knuth MW, Lesley SA: Combining the polymerase incomplete primer extension method for cloning and mutagenesis with microscreening to accelerate structural genomics efforts. Proteins. 2008, 71: 982-994. 10.1002/prot.21786.View ArticleGoogle Scholar
- Klock HE, Lesley SA: The Polymerase Incomplete Primer Extension (PIPE) method applied to high-throughput cloning and site-directed mutagenesis. Methods Mol Biol. 2009, 498: 91-103. 10.1007/978-1-59745-196-3_6.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.